IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET): study protocol - Nochi, Zahra; Pia, Hossein; Bloms-Funke, Petra; Boesl, Irmgard; Caspani, Ombretta; Chapman, Sonya C.; Fardo, Francesca; Genser, Bernd; Götz, Marcus; Kostenko, Anna; Leone, Caterina; Li, Thomas; et al. (Trials, 2022)
Gesehen am 14.05.2024